Ticker Symbol: XBIT
XBiotech Inc
$14.04 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001626878
Company Profile
XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. Utilizing natural human immunity as a source of new medicines offers the potential to redefine the standards of care for a wide range of diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Building 4
Website: www.xbiotech.com
CEO: John Simard
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $3.81
Change:
-$0.04
(
-1.04%)
Days Range: $3.60 - $3.86
Beta: -
52wk. High: $6.69
52wk. Low: $3.00
Ytd. Change 8.65%
50 Day Moving Average: $4.23
200 Day Moving Average: $4.69
Shares Outstanding: 30435714
Valuation
Market Cap: 11.6B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A